Inovio Pharmaceuticals Files 8-K on Security Holder Vote

Ticker: INO · Form: 8-K · Filed: May 22, 2025 · CIK: 1055726

Inovio Pharmaceuticals, INC. 8-K Filing Summary
FieldDetail
CompanyInovio Pharmaceuticals, INC. (INO)
Form Type8-K
Filed DateMay 22, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, shareholder-vote

Related Tickers: INO

TL;DR

INO filing 8-K: Shareholders voting on something. Details TBD.

AI Summary

On May 20, 2025, Inovio Pharmaceuticals, Inc. filed an 8-K report detailing a submission of matters to a vote of security holders. The filing does not specify the nature of the vote or any associated resolutions.

Why It Matters

This filing indicates a procedural step where Inovio is seeking approval from its shareholders on certain matters, which could have implications for corporate governance or future strategic decisions.

Risk Assessment

Risk Level: low — The filing is procedural and does not disclose specific financial or operational risks at this time.

Key Players & Entities

FAQ

What specific matters are being submitted for a vote of security holders?

The filing does not specify the exact matters being submitted for a vote, only that such a submission has occurred.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on May 20, 2025.

What is the Commission File Number for Inovio Pharmaceuticals, Inc.?

The Commission File Number is 001-14888.

In which state is Inovio Pharmaceuticals, Inc. incorporated?

Inovio Pharmaceuticals, Inc. is incorporated in Delaware.

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report the submission of matters to a vote of security holders.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 22, 2025 regarding INOVIO PHARMACEUTICALS, INC. (INO).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing